Krebs Biochemicals & Industries Limited (BOM:524518)
59.00
+0.12 (0.20%)
At close: Nov 16, 2026
BOM:524518 Revenue
Krebs Biochemicals & Industries had revenue of 57.90M INR in the quarter ending September 30, 2026, with 38.94% growth. This brings the company's total for the last twelve months to 268.57M, down -1.32% year-over-year. In the fiscal year ending March 31, 2026, Krebs Biochemicals & Industries had annual revenue of 237.32M, down -45.21%. That makes Krebs Biochemicals & Industries the 41,616th largest company in the world by revenue and 4,186th in India.
Revenue (ttm)
268.57M
Revenue Growth
-1.32%
P/S Ratio
4.74
Revenue / Employee
1.89M
Employees
142
Market Cap
1.27B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 237.32M | -195.80M | -45.21% |
| Mar 31, 2025 | 433.12M | -71.10M | -14.10% |
| Mar 31, 2024 | 504.22M | -17.13M | -3.29% |
| Mar 31, 2023 | 521.34M | -75.69M | -12.68% |
| Mar 31, 2022 | 597.03M | 70.20M | 13.32% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.20B |
| Resonance Specialties | 1.14B |
| Smruthi Organics | 1.12B |
| Panchsheel Organics | 1.10B |
| Kimia Biosciences | 1.04B |
| Tyche Industries | 503.78M |
| Accretion Nutraveda | 489.95M |
| Himalaya Nutravedics India | 430.68M |
Krebs Biochemicals & Industries News
- 1 year ago - Krebs Biochemicals & Industries halts production following order from Andhra Pradesh Pollution Control Board - Business Upturn